Tag: ARCA Biopharma
May 13, 2019
ARCA biopharma Submits Patent Application to US Patent and Trademark Office for Atrial Fibrillation
ARCA biopharma (NASDAQ:ABIO) has announced it has filed a provisional patent application with the US Patent and Trademark Office covering... May 1, 2019
ARCA biopharma Shares Published Paper Showing Trial Results
ARCA biopharma announced the publication of a paper showing GENETIC-AF Phase 2B trial results. December 21, 2018
ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
ARCA biopharma (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced... July 31, 2018